alexa
Reach Us +1-504-608-2390
Jianfei Yang | OMICS International
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jianfei Yang

Jianfei Yang
Principal Scientist and a Project Leader
Tempero Pharmaceuticals
USA

Biography

Dr. Jianfei Yang is Principal Scientist and a Project Leader of a Th17 cell-related project at Tempero Pharmaceuticals, a GSK company, in Cambridge, MA, USA. He received a PhD in Pathology from Niigata University in Japan in 1997. He then obtained postdoctoral training in Dr. Ken Murphy’s lab at HHMI and Washington University. In the past 16 year, he has been studying the role of CD4+ T helper cells in immunity and diseases. He has more than 10 years of experience in autoimmune disease research and pharmaceutical drug development. He has published numerous papers and patents. Dr. Jianfei research interests include the role of Th17/Treg cells in protective immunity, autoimmune and inflammatory diseases, and tumor immunology; therapeutic monoclonal antibodies and small molecules for the treatment of various diseases.

Research Interest
The role of Th17/Treg cells in protective immunity, autoimmune and inflammatory diseases, and tumor immunology; therapeutic monoclonal antibodies and small molecules for the treatment of various diseases.
Publications

Global Speakers in the subject

Global Experts in the subject

Top